Trxade Health Inc

-0.03 (-5.44%)
Earnings Announcements

TRxADE Health Inc Reports Quarterly Net Loss Of $0.06 Per Basic And Diluted Share Outstanding

Published: 11/07/2022 22:16 GMT
Trxade Health Inc (MEDS) - Trxade Health Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results.
Trxade Health Inc - Consolidated Revenues for Q3 of 2022 Compared to Q3 of 2021, Decreased 6% to $2.4 Million.
Trxade Health Inc - Qtrly Net Loss of $0.06 per Basic and Diluted Share Outstanding.
Revenue is expected to be $2.51 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $2.84 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.